Hidradenitis Suppurativa Awareness Week

Summary#

HJR-71, titled Hidradenitis Suppurativa Aware, is an introduced Illinois House joint resolution; it does not create or amend a statute. If adopted by the House and Senate, it would declare June 1 through June 9, 2026, Hidradenitis Suppurativa Awareness Week in Illinois. Its stated goal is to increase awareness and support better diagnosis, research, treatment and access to care.

  • The resolution recognizes the importance of public and health-professional education, timely diagnosis, research, effective treatments and access to care. These are statements of support, not requirements to provide those things.
  • It directs that a suitable copy of the resolution be delivered to the Illinois Department of Public Health, but does not name who must deliver it.
  • The resolution describes June 1 through June 9 as an awareness “week.” That is the date range in the operative text; it is nine days.
  • The resolution includes claims about HS and its effects, but the supplied material does not independently verify them.

What it means for you#

  • People with HS and caregivers: The resolution expresses support for awareness and improved care. It does not create a new treatment, benefit, right to care, or way to apply for services.
  • Health professionals and the public: It recognizes the importance of education and timely diagnosis, but does not require training, screening or other action.
  • Illinois Department of Public Health: The resolution directs delivery of a copy. It does not assign the department a new program or ongoing duties.
  • General public: The dates named are in the past: the resolution was introduced in November 2026, while the declared period is June 1–9, 2026. The text does not explain this timing.

Money#

No publicly available information.

  • The resolution does not specify spending, staffing, fees or other costs.

What is unclear#

  • Whether the House and Senate will adopt the resolution; it is listed as introduced.
  • Who is responsible for delivering a copy to the Department of Public Health.
  • Whether any public education, research or care efforts will follow. The resolution sets no plan, funding, deadlines or reporting requirements.
  • Why the operative dates are June 1–9, 2026, even though the resolution was introduced after those dates.

Case for#

  • The resolution appears intended to draw attention to HS and the challenges it describes, including delayed diagnosis and physical and psychological distress.
  • A possible argument for recognizing awareness dates is that it can signal support for education, research and better access to care without setting a specific program in law.
  • The resolution identifies patients and caregivers as groups whose quality of life matters.

Case against#

  • The resolution does not require public education, screening, research funding or expanded access to treatment, so its practical effect may be limited to recognition.
  • It does not identify who would carry out the goals or how progress would be measured.
  • The dates fall before the resolution’s introduction, and the text calls a nine-day period a “week.”